The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure-Reference-Cited by-同舟云学术

The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure

Published:2020-07-20 Issue:5 Volume:7 Page:2871-2883
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Mustroph Julian¹,Drzymalski Marzena¹,Baier Maria¹,Pabel Steffen¹,Biedermann Alexander¹,Memmel Bernadette¹,Durczok Melanie¹,Neef Stefan¹,Sag Can Martin¹,Floerchinger Bernhard²,Rupprecht Leopold²,Schmid Christof²,Zausig York³,Bégis Guillaume⁴,Briand Veronique⁴,Ozoux Marie‐Laure⁴,Tamarelle Dorothee⁴,Ballet Veronique⁴,Janiak Philip⁴,Beauverger Philippe⁴,Maier Lars S.¹,Wagner Stefan¹

Affiliation:

1. Department of Internal Medicine II University Medical Center Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg Germany

2. Department of Cardiothoracic Surgery University Medical Center Regensburg Regensburg Germany

3. Department of Anesthesiology University Medical Center Regensburg Regensburg Germany

4. Sanofi Research & Development (R&D) Chilly‐Mazarin France

Funder

Deutsche Forschungsgemeinschaft

Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.

Universität Regensburg

Deutsches Zentrum für Herz-Kreislaufforschung

Deutsche Stiftung für Herzforschung

Publisher